Cargando…
Improved survival in several cancers with use of H(1)-antihistamines desloratadine and loratadine
BACKGROUND: We have previously shown an association with substantially improved survival in breast cancer and melanoma for desloratadine and loratadine users, and set out to find whether an improved survival can be seen in tumors with and without a known response to immune checkpoint therapy, such a...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Neoplasia Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868613/ https://www.ncbi.nlm.nih.gov/pubmed/33550204 http://dx.doi.org/10.1016/j.tranon.2021.101029 |